Predictors of response to 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of actinic keratosis: A post hoc analysis of a phase III, randomized, vehicle-controlled trial

被引：0

作者：

Stockfleth, Eggert ^{[1
]}

Ryan, John ^{[2
]}

Falques, Meritxell ^{[3
]}

Ivanoff, Nathalie ^{[3
]}

Rodriguez Azeredo, Rosario ^{[3
]}

Vilardell, David ^{[3
]}

机构：

[1] St Josef Hosp, Bochum, Germany

[2] Alverton Practice, Penzance, England

[3] Almirall SA, Barcelona, Spain

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

5225

引用

页码：AB202 / AB202

页数：1

共 19 条

[1] Evaluation of 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of actinic keratosis: a Phase III, randomised, vehicle-controlled trial
Stockfleth, E.
von Kiedrowski, R.
Dominicus, R.
Ryan, J.
Ellery, A.
Falques, M.
Ivanoff, N.
Rodriguez Azeredo, R.
MELANOMA RESEARCH, 2016, 26 : E10 - E10
[2] Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
Stockfleth, Eggert
von Kiedrowski, Ralph
Dominicus, Rolf
Ryan, John
Ellery, Adam
Falques, Meritxell
Ivanoff, Nathalie
Rodriguez Azeredo, Rosario
DERMATOLOGY AND THERAPY, 2017, 7 (01) : 81 - 96
[3] Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
Eggert Stockfleth
Ralph von Kiedrowski
Rolf Dominicus
John Ryan
Adam Ellery
Meritxell Falqués
Nathalie Ivanoff
Rosario Rodriguez Azeredo
Dermatology and Therapy, 2017, 7 : 81 - 96
[4] Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
Eggert Stockfleth
Ralph von Kiedrowski
Rolf Dominicus
John Ryan
Adam Ellery
Meritxell Falqués
Nathalie Ivanoff
Rosario Rodriguez Azeredo
Dermatology and Therapy, 2017, 7 : 263 - 263
[5] Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial (vol 7, pg 81, 2017)
Stockfleth, Eggert
von Kiedrowski, Ralph
Dominicus, Rolf
Ryan, John
Ellery, Adam
Falques, Meritxell
Ivanoff, Nathalie
Rodriguez Azeredo, Rosario
DERMATOLOGY AND THERAPY, 2017, 7 (02) : 263 - 263
[6] Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trial
Ulrich, M.
Reinhold, U.
Falques, M.
Rodriguez Azeredo, R.
Stockfleth, E.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (03) : 390 - 396
[7] In vivo Reflectance Confocal Microscopy Characterization of Field-Directed 5-Fluorouracil 0.5%/Salicylic Acid 10% in Actinic Keratosis
Ulrich, Martina
Alarcon, Ivette
Malvehy, Josep
Puig, Susana
DERMATOLOGY, 2015, 230 (03) : 193 - 198
[8] Randomized, vehicle-controlled trials of topical 5-fluorouracil therapy for actinic keratosis treatment: an overview
Rhavar, Maral
Lamel, Sonia A.
Maibach, Howard I.
IMMUNOTHERAPY, 2012, 4 (09) : 939 - 945
[9] Cost-effectiveness analysis of 5-fluorouracil 0.5%/salicylic acid 10% in the treatment of actinic keratosis in Spain
Nieves, Diana
Puig-Peiro, Ruth
Ferrandiz, Carlos
Josep Plazas, Maria
Brosa, Max
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2015, 15 (03) : 539 - 543
[10] Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery - A randomized, vehicle-controlled clinical trial
Jorizzo, J
Weiss, J
Furst, K
VandePol, C
Levy, SF
ARCHIVES OF DERMATOLOGY, 2004, 140 (07) : 813 - 816

← 1 2 →